Use of conventional or replicating nucleic acid-based vaccines and recombinant Semliki forest virus-derived particles for the induction of immune responses against hepatitis C virus core and E2 antigens. (Q43000576)
Jump to navigation
Jump to search
scientific article published in October 2000
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Use of conventional or replicating nucleic acid-based vaccines and recombinant Semliki forest virus-derived particles for the induction of immune responses against hepatitis C virus core and E2 antigens. |
scientific article published in October 2000 |
Statements
Use of conventional or replicating nucleic acid-based vaccines and recombinant Semliki forest virus-derived particles for the induction of immune responses against hepatitis C virus core and E2 antigens (English)
Vidalin O
Fournillier A
Renard N
Chen M
Depla E
Boucreux D
Baumert T
Nakano I
Fukuda Y
Trépo C
Inchauspé G
1 October 2000